Zurich Cantonal Bank
ASMB icon

Zurich Cantonal Bank’s Assembly Biosciences ASMB Stock Holding History

Zurich Cantonal Bank’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-390
Closed -$22K – 2602
2021
Q1 		$22K Hold
390
– – ﹤0.01% 2518
2020
Q4 		$28K Hold
390
– – ﹤0.01% 2547
2020
Q3 		$77K Buy
390
+304
+353% +$76.6K ﹤0.01% 2102
2020
Q2 		$24K Hold
86
– – ﹤0.01% 2426
2020
Q1 		$15K Hold
86
– – ﹤0.01% 2401
2019
Q4 		$21K Hold
86
– – ﹤0.01% 2487
2019
Q3 		$10K Hold
86
– – ﹤0.01% 2548
2019
Q2 		$14K Hold
86
– – ﹤0.01% 2534
2019
Q1 		$20K Hold
86
– – ﹤0.01% 2410
2018
Q4 		$23K Hold
86
– – ﹤0.01% 2401
2018
Q3 		$38K Buy
+86
New +$40.3K ﹤0.01% 2282
2017
Q2 		– Sell
-400
Closed -$122K – 2525
2017
Q1 		$122K Buy
+400
New +$98.1K ﹤0.01% 1218

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Zurich Cantonal Bank's ASMB Position: Q2 2021 in Review

Zurich Cantonal Bank sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 390 shares — an estimated $22K sold.

Zurich Cantonal Bank first reported a position in ASMB in Q1 2017 and held it in 12 quarters. The position peaked at $122K in Q1 2017. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Zurich Cantonal Bank reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 390 Assembly Biosciences shares in Q2 2021, an estimated $22K.
  • Zurich Cantonal Bank first reported a position in Assembly Biosciences in Q1 2017 and held it in 12 quarters.
  • Zurich Cantonal Bank's Assembly Biosciences position peaked at $122K in Q1 2017.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Zurich Cantonal Bank's 13F filing for Q2 2021, filed 30 Jul 2021.